Loading companies…
United States · Healthtech
A minimally invasive implant system designed to relieve urinary symptoms caused by an enlarged prostate.
Zenflow’s Spring System is a small implant delivered in a urologist’s office to relieve symptoms of benign prostatic hyperplasia. The approach is designed to offer a procedural option for men whose symptoms can include urinary frequency, urgency and disrupted sleep. Zenflow’s Series D proceeds are intended to support commercialization, alongside an exclusive U.S. distribution partnership with Cook Medical.
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series D | $52M | ClavystBio — ParticipantF-Prime — ParticipantTrinity Capital — Participant |